Market ExpansionRetail pharmacy contracts finalized with major chains, regional grocers, merchants, buying groups, and independent chains — a total of 17k+ locations vs. FY23.
Partnership And Financial StrengthThe Sanofi deal is bolstering the balance sheet and advancing the company's own flu+/-CV19 into Phase 3 soon.
Product AvailabilityNovavax COVID-19 vaccine availability exceeds 90% of the 2023/24 season distribution, with a significant presence in national locations and as the only non-mRNA option in online schedulers.